Tharimmune, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 9.32 million compared to USD 8.47 million a year ago. Basic loss per share from continuing operations was USD 7.14 compared to USD 18.72 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.332 USD | +1.84% | -9.72% | -34.68% |
May. 22 | Tharimmune to Implement 1-for-15 Reverse Stock Split | MT |
May. 09 | Tharimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.68% | 3.84M | |
+10.59% | 115B | |
+11.83% | 106B | |
-5.91% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.52% | 17.56B | |
-40.50% | 17.32B | |
+6.53% | 14.03B | |
+30.87% | 12.13B |
- Stock Market
- Equities
- THAR Stock
- News Tharimmune, Inc.
- Tharimmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023